This could have been a fantastic week, even if OPTI:Optibiotix had just
stayed still. However, despite a recent trading statement that was frankly
amazing, the share price is still drifting. A 2p drop this week cost over
£2,200 so it shows how well everything else did when the overall losses were
only £601. The deficit between cost and value widened to £35,097 and overall
potfolio value is £83,714.
Only one share had a significant percentage loss this week, with
WRES:W Resources dropping 9% as it became clear production levels are
so low that they are not making ends meet. Glad I only trusted a small amount
to this donkey.
CAML:Central Asia Metals climbed 5% and is making steady progress as
the price of copper increases, despite having suspended the dividend. My SIPP
holding is only 10% down now.
N4P:N4 Pharma also increased 5% but I don't know why. I still hold out
very little hope of these remaining solvent.
TLOU:Tlou Energy technically stayed the same price, but I succeeded in
getting my entire application of 8,809 open offer shares at 2.2p costing
£193.80 with no commission. As that's the current bid price, it meant a 5%
improvement on bid price compared to average purchase price. I now have
40,000 shares so just have to wait for the power purchase agreement and
financing to be finalised and I'm convinced this will be a great investment.
APAX:Apax Global Alpha is one of my new magic formula shares and
climbed an impressive 8% this week after a portfolio update. They are now 4%
up and in profit by £36.
Share of the week is JLP:Jubilee Metals, climbing a whopping 21% and
going £372 into profit. I was so excited about prospects that I spent my ISA
SBTX:SkinBioTherapeutics cash on another 37,604 shares at 3.997p
costing £1,514.98. Given the price ended the week at 4.6p, these have already
made a decent profit. We're only just back around pre-covid prices and metal
prices have risen significantly, so I'm now of a mind to hold these for much
longer than I originally anticipated, Not sure how I'm going to get back into
SBTX though...
Cost isn't quite back to where it was before recent sales so I still have some
ammo. Value actually dipped slightly.
Despite the slight drop we're still above the trend line, but dropping at the
same rate.
The ISA and share accounts look like this
| Weekly Change | |||
| Cash |
£14.48 |
-£1,708.78 | |
| Portfolio cost | £62,366.49 | +£1,708.78 | |
| Portfolio sell value (bid price-commission) | £42,401.64 | (-33.1%) | -£997.14 |
| Potential profits | £372.89 | +£372.89 | |
| Yr 5 Dividends | £0.85 | +£0 | |
| Yr 5 Profit from sales | £35.20 | +£0 | |
| Yr 5 Average monthly cash profit | -£0.44 | (-0%) | +£0.01 |
| Total Dividends | £1,343.15 | +£0 | |
| Total Profit from sales | £20,426.61 | +£0 | |
| Average monthly cash profit | £360.33 | (6.9%) | -£1.40 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Performance/Injection | 10.4% | +0% | |
| Compound performance | 52% | +0% |
Cash is down by the cost of the JLP:Jubilee Metals shares and the
TLOU:Tlou Energy open offer. The difference between cost and value
worsened by £997 due to the OPTI:Optobiotix drop. Best news is
JLP:Jubilee Metals getting into profit at last, and £372 potential profit is
great given it was down by about 15% last week.
Still just above the injection line despite the drop
Only just above the trend line, but we've been the right side for 2 months
now, so there is hope.
The SIPP looks like this after week 243
| Weekly Change | ||||
| Cash | £1,485.74 | -£916.14 | ||
| Portfolio cost | £52,370.64 | +£1,016.14 | ||
|
Portfolio sell value (bid price - commission) |
£38,122.54 | (-27.2%) | -£303.75 | |
| Potential profits | £75.98 | +£32.91 | ||
| Yr 5 Dividends | £28.67 | +£0 | ||
| Yr 5 Interest | £0.03 | +£0 | ||
| Yr 5 Profit from sales | £765.90 | +£0 | ||
| Yr 5 Average monthly cash profit | £84.53 | (1.9%) | -£2.49 | |
| Total Dividends | £1,927.91 | +£0 | ||
| Total Interest | £0.20 | +£0 | ||
| Total Profit from sales | £13,315.00 | +£0 | ||
| Average monthly cash profit | £261.93 | (6.0%) | -£1.08 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Performance/Injection | 9% | +0% | ||
| Compound performance | 42% | +0% |
My discipline to hold cash to buy back SBTX:SkinBioTherapeutics failed
utterly as I've been watching PAY:Paypoint as the next potential
addition to my magic formula portfolio. I decided the time was right, and so
bought 178 shares at 561.34p costing £1,016.14 with commission and stamp duty.
The timing was quite good as by the end of the week they were up 3% and £31 in
profit. The cash dropped by £100 less than the purchase price as the tax
rebate got paid in.
Despite being a good week, the difference between cost and value worsened by
£303 thanks to the OPTI:Optibiotix drop. Potential profits rose by £32
and there are three shares in profit, with APAX:Apax Global Alpha up
£37, FXPO:Ferrexpo losing ground but still £8 in profit, and
PAY:Paypoint up £31.
There is still £1,485 left in cash for re-buying
SBTX:SkinBioTherapeutics, and £2,000 pension transfer to add to it in a
few weeks. Given I've used up my SBTX cash on
JLP:Jubilee Metals in my ISA, I'm planning to put all £3,485 into
SBTX when the price is right.
You can hardly see the dip
No sign of making the recovery stick - yet.
Here's the trading account after week 209
| Weekly Change | |||
| Cash | £732.67 | +£516.62 | |
| Portfolio cost | £1,842.21 | -£511.93 | |
| Portfolio sell value (bid price - commission) | £957.22 | (-48.0%) | +£7.28 |
| Potential profits | £0 | -£21.84 | |
| Year 5 Dividends | £0 | +£0 | |
| Year 5 Profit | £154.70 | +£154.70 | |
| Yr 5 Average monthly cash profit | £670.35 | (436.7%) | +£670.35 |
| Dividends | £47.92 | +£0 | |
| Profit from sales | £441.07 | +£154.70 | |
| Average monthly cash profit | £10.14 | (6.6%) | +£3.18 |
|
(Sold stocks profit + Dividends - Fees / Months) |
I sold my JLP:Jubilee Metals shares for 4.73p after buying at 3.4815p
making £154.69 (29.5%) profit. Cash only went up by £516 as I pulled out £150
to reduce the injection to £2,000. That's £500 of the original injection
that's been banked. The difference between cost and value improved by £7 as
there were gains and losses in the other shares.
This is week 1 of year 5, so with the sale and projected performance over the
next 12 months, the figure of £670 a month is crazy. That will settle down
over the weeks, unless of course I manage to maintain £150 a week performance,
which is highly unlikely. Long term performance improved to £10 a month so I'm
finally starting to see a decent return.
What to buy next? Unfortunately SBTX:SkinBioTherapeutics has climbed
back to 20p instead of dropping. I'm almost tempted to buy
OPTI:Optibiotix, but vowed not to sell any so that's off the table. I
need to see if anything has been clobbered recently that may recover. Looking
at my existing portfolio there is one candidate. TLOU:Tlou Energy has
just done an open offer and the share price has slumped to that figure. There
could be potential for a short term recovery, and the announcment of resumed
de-watering could see a spike. None of the rest of my existing portfolio look
like a good candidate.
Cost and value have suddenly come very close together following the sale all
going into cash and supporting the green line. When I buy again the red line
will return to where it was, but green line will stay behind.
Very little change here as the sale and profit taking don't impact this chart.
Only the difference between cost and value of actual shares matters here.
The virtual magic formula portfolio was down by 15.02% last week and is now
down by 15.12% so very little change. There are now 7 shares in profit and the
same three down by more than 50%. Maybe I should be checking those as
potential trading shares?
How did we do with last weeks wishes?
As predicted we had another OPTI:Optibiotix Wellbiome announcement that
didn't stir the market and didn't prevent the drop, so the SweetBiotix
announcement is still awaited. That wish carries over. My wish for
JLP:Jubilee Metals was to get to 5p. I didn't think that was going to
happen so happy I sold at 4.7p and decided to keep my ISA holding longer term.
The climb to 4.6p in my ISA was good, and 5p is still on my wish list for next
week.
I wished one of APAX:Apax Global Alpha or
POLR:Polar Capital Holdings getting into profit did come true, as
APAX made it. My wish for this week is for POLR to join them.
Still no sign of MTFB:Motif Bio announcing a reverse takeover. We have
until Tuesday, so it's looking grim.
I feel bad wishing for SBTX to drop in price, but I want to buy back
in, and it needs to get down to 16p. If I never get back in then I'll just
have to rely on the OPTI:Optibiotix dividend. I guess that my other
wish is I find a suitable share for the trading account.
No comments:
Post a Comment